Gold vs US Dollar

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Galectin Therapeutics Inc (GALT)
Galectin Therapeutics Inc (GALT) Financials

GALT Galectin Therapeutics Inc

1.24

-0.01 (-0.80%)

17 Jan 2025 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-105.917	-175.055	-228.556	-70.221	-60.466	-85.956	-123.187	-181.085
Return on Equity (%)	-157.772	-357.857	-647.879	-82.284	-71.153	-262.792	235.423	93.46
Return on Invested Capital (%)	-151.588	-291.591	-359.129	-51.541	-67.439	-108.24	-195.22	-407.253
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	0.234	0.026	0.12	0.571	0.303	0.032	-0.391	-0.717
Earnings Per Share	-0.509	-0.374	-0.261	-0.253	-0.295	-0.373	-0.472	-0.529
Cash Per Share	0.35	0.065	0.143	0.595	0.339	0.482	0.226	0.303
Working Capital Per Share	0.274	0.018	0.117	0.569	0.301	0.399	0.092	0.142
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-0.488	-0.347	-0.241	-0.167	-0.293	-0.371	-0.471	-0.485
EBITDA Per Share	-0.488	-0.347	-0.241	-0.167	-0.293	-0.371	-0.471	-0.485
Free Cash Flow Per Share	-0.509	-0.374	-0.261	-0.253	-0.296	-0.374	-0.472	-0.529

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	32.91M	35.79M	41.19M	56.9M	57.08M	59.34M	59.43M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	59.43M	N/A	59.58M	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	78.45M
Price to Earnings Ratio	-1.74
Price to Sales Ratio	0
Price to Cash Ratio	3.03
Price to Book Ratio	-1.29
Dividend Yield	-

Share Statistics

Shares Outstanding	62.76M
Average Volume (1 week)	301.5k
Average Volume (1 Month)	1.54M
52 Week Change	-31.11%
52 Week High	4.2684
52 Week Low	0.726041

More Ratios Coming Soon!

Galectin Therapeutics

EN EUROZ 60EW GR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions